DYEE Capital

Degron Therapeutics is a prominent platform company focused on discovering molecular glue degraders aimed at cancer treatment. The company specializes in developing small-molecule drugs that leverage its innovative protein degradation technology. By utilizing a molecular glue-based approach, Degron Therapeutics aims to create new therapeutic options that enhance treatment efficiency for patients with cancer. Through its research and development efforts, the company seeks to advance the field of targeted therapy and improve clinical outcomes.

Suzhou MicroClear Medical Instruments Co., Ltd designs, manufactures, sells, and services advanced optical imaging-instruments and high-resolution biomedical imaging devices. It offers hand-held fundus cameras and confocal retina ophthalmoscopes; and hand-held anterior segment observation, hand-held ENT system and dermatology observation, and fundus tomography products. The company also offers installation and maintenance services, and spare parts. It offers its products through a network of distributors. The company was founded in 2011 and is based in Suzhou, China.

Cloudbreak Therapeutics LLC is a clinical-stage biotechnology company based in Irvine, California, focused on developing ocular drugs for conditions such as glaucoma and pterygium. Founded in 2015, the company utilizes a capital-efficient business model that repurposes approved systemic drugs for ocular delivery. By prioritizing the rapid advancement of drug candidates through proof-of-concept Phase II clinical trials, Cloudbreak Therapeutics aims to out-license global rights for Phase III trials, product registration, and commercialization. The company strategically collaborates with contract research organizations to manage non-clinical, chemistry, manufacturing, and clinical development, thus maximizing its resources for effective drug development.

GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative pharmaceuticals and antibody drugs that target various cancer systems. Its efforts are directed at reactivating tumor-specific immune responses and mobilizing the body's own immune system to combat cancer. GenFleet Therapeutics serves both domestic and international markets, contributing to advancements in cancer therapy through its development of signal transduction regulators, tumor microenvironment modulators, and transcription factors.

Zhimeng Biopharma, Inc. is a pharmaceutical company based in Shanghai, China, established in 2017. The company focuses on developing innovative treatments for chronic hepatitis B (CHB) and related liver diseases, with a pipeline that includes a HBV capsid inhibitor, HBsAg inhibitor, and various immunomodulators. In addition to its work on hepatitis B, Zhimeng is also advancing small molecule drugs aimed at treating neurological disorders, including epilepsy, pain, and strokes. The company's research targets multiple stages of the hepatitis B virus, with the goal of enhancing treatment options available to healthcare professionals and improving patient outcomes.

Developer and provider of bio pharmaceutical products designed to create antibodies for the treatment of cancer. The company's research focuses on tumor immunotherapy antibody projects and drugs for cancer treatments, enabling patients to receive tumor and cancer medical treatment and support, improving their conditions.

Ionova Life Science Co., Ltd. is a biotechnology company based in Shenzhen, China, with additional offices in Hong Kong, Macao, and the Greater Bay Area. Founded in 2016, the company focuses on the discovery and development of novel medicines for cancer treatment, specializing in oncology, immuno-oncology, and tumor-targeted therapies. Ionova employs an in-house built discovery platform to facilitate the development of innovative anti-tumor drugs and immunomodulatory agents. Through its research efforts, the company aims to advance treatments that specifically target tumors and enhance the immune response against cancer.

Elpiscience Biopharmaceuticals Co., Ltd. operates as an immunology company that develops immunotherapies to treat cancer. The company is based in Pudong, China with an additional office in Suzhou, China.

Phanes Therapeutics, Inc. is a biotechnology company based in San Diego, California, established in 2016. It specializes in the discovery and development of therapeutics aimed at treating solid tumors and eye diseases. The company's portfolio includes a monoclonal antibody designed for solid tumors and various ophthalmic conditions such as age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. Additionally, Phanes Therapeutics is developing a bispecific antibody targeting small cell lung cancer. With a focus on scientific innovation, the company strives to create advanced therapeutic options that enhance patient care and improve lives worldwide.

SceneRay Corporation, Limited is a medical device company based in Suzhou, China, specializing in the design, development, and distribution of neuromodulation devices. The company offers a range of products, including a deep brain stimulation system that features an implantable neuro-stimulator, patient controller, and various accessories. Additionally, SceneRay develops spinal cord stimulation and sacral nerve stimulation systems. The team at SceneRay comprises experts with extensive experience in neuromodulation device development, manufacturing, and marketing, and the company holds numerous patents in this field. Committed to advancing neuromodulation solutions, SceneRay aims to provide patients with high-quality and effective treatments.

Developer of biological R&D platform intended to discover antibody new drugs. The company develops antibody drugs to better treat cancer and tumor diseases, enabling patients to get better treatments.

Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, focused on discovering and developing therapeutics for unmet medical needs, particularly in respiratory viral infections and viral hepatitis. Founded in 2013, the company is dedicated to addressing global health challenges with its innovative products, which include AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences aims to establish itself as a leader in antiviral drug development through a commitment to scientific excellence and innovation.

InventisBio Inc. is a biotechnology company focused on discovering and developing innovative therapeutics for cancer and metabolic diseases. Founded in 2013 and based in Pudong, China, the company is advancing a pipeline of small molecule drug candidates targeting lung cancer, breast cancer, and gout. Notably, it is developing D-0316, a third-generation EGFR-T790M tyrosine kinase inhibitor, and is exploring combinations of its drugs with other immuno-oncology therapies, such as PD-1 antibodies, for various cancer indications. Co-founded by Dr. Yaolin Wang and a team of scientists with prior experience at major pharmaceutical companies like Merck and Schering-Plough, InventisBio aims to leverage their expertise in oncology and metabolic diseases to bring effective treatments to market.

LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.

Elpiscience Biopharmaceuticals Co., Ltd. operates as an immunology company that develops immunotherapies to treat cancer. The company is based in Pudong, China with an additional office in Suzhou, China.

Ionova Life Science Co., Ltd. is a biotechnology company based in Shenzhen, China, with additional offices in Hong Kong, Macao, and the Greater Bay Area. Founded in 2016, the company focuses on the discovery and development of novel medicines for cancer treatment, specializing in oncology, immuno-oncology, and tumor-targeted therapies. Ionova employs an in-house built discovery platform to facilitate the development of innovative anti-tumor drugs and immunomodulatory agents. Through its research efforts, the company aims to advance treatments that specifically target tumors and enhance the immune response against cancer.

A1Food is a food and snacks brand which mainly sells nuts and pastry. Its products offered includes nut set, nut seaweed, oxcake, and blasting liquid crisp. A1Food food sells its product online. The company was founded in 2018 and is headquartered in Xiamen, Fujian.

Shanghai Allist Pharmaceuticals Co., Ltd. is a pharmaceutical company focused on the discovery, development, and commercialization of products aimed at improving human health. Established in 2004 and based in Shanghai, China, the company offers both generic and branded pharmaceuticals, specifically targeting treatments for cardiovascular diseases, acid-related disorders, and cancer. Allist Pharmaceuticals is recognized for its innovative approaches, particularly in the field of cancer treatment, and operates both domestically and internationally to expand its reach in the pharmaceutical market.

Hebaodan is a S2B2C e-commerce platform.

Zongmu Technology Co. Ltd, founded in January 2013 and headquartered in Shanghai, specializes in the development of advanced driving assistance systems (ADAS) and autonomous driving technologies. The company has established itself as a leader in the SurroundView ADAS market within China, providing innovative solutions and integration services to various automotive manufacturers. Zongmu operates research and development centers in Beijing and Shenzhen, and has formed strategic partnerships with numerous original equipment manufacturers (OEMs) and their tier-one suppliers. Its product offerings include 2D and 3D panoramic vision systems, self-parking solutions, and driving recording systems, all aimed at enhancing vehicle safety and improving the driving experience.

Weijiechengpei is a third-party logistics service provider based in urban areas, specializing in the distribution of goods for sectors such as catering, retail, and fresh e-commerce. Operating under the service brand Shanghai Kexin Logistics Co., Ltd., the company employs a model that combines consultation with logistics services. It focuses on B2B logistics management, particularly for restaurant and retail chains, and emphasizes logistics integration and the construction of B2B logistics networks. Weijiechengpei offers a range of services, including warehousing, distribution, packaging, and supply chain consulting, aimed at enhancing operational efficiency for its clients in the fast-moving consumer goods market and beyond.

FineEx is a logistics service platform based in Shanghai, specializing in warehousing, distribution, and cash-on-delivery (COD) services tailored for small and medium-sized e-commerce businesses. Originally established as Shanghai Heyi Logistics Co., Ltd. in 2006, FineEx has evolved into a significant player in the logistics sector by integrating warehousing and distribution within the logistics supply chain. The company leverages a national warehousing network and a self-developed logistics system to enhance operational efficiency. By offering comprehensive logistics solutions, FineEx enables brand owners and distributors to reduce warehousing costs, improve inventory turnover, and enhance delivery efficiency, thereby contributing to an improved customer experience in both e-commerce and traditional retail sectors.

Borns Robot Co., Ltd. manufactures surgical robots, providing digital diagnosis and treatment solutions for doctors and patients. The company is headquartered in Chongqing, China with additional office in Chengdu, China.

KTVme is a digital entertainment platform.

A1Food is a food and snacks brand which mainly sells nuts and pastry. Its products offered includes nut set, nut seaweed, oxcake, and blasting liquid crisp. A1Food food sells its product online. The company was founded in 2018 and is headquartered in Xiamen, Fujian.

Weijiechengpei is a third-party logistics service provider based in urban areas, specializing in the distribution of goods for sectors such as catering, retail, and fresh e-commerce. Operating under the service brand Shanghai Kexin Logistics Co., Ltd., the company employs a model that combines consultation with logistics services. It focuses on B2B logistics management, particularly for restaurant and retail chains, and emphasizes logistics integration and the construction of B2B logistics networks. Weijiechengpei offers a range of services, including warehousing, distribution, packaging, and supply chain consulting, aimed at enhancing operational efficiency for its clients in the fast-moving consumer goods market and beyond.